You have 9 free searches left this month | for more free features.

clofarabine

Showing 26 - 50 of 172

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Autoimmune Disease, Crohn Disease, Inflammatory Disorder Trial in Los Angeles (Computed Tomography, Fluorine F 18 Clofarabine,

Completed
  • Autoimmune Disease
  • +5 more
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 2, 2020

18F-Clofarabine PET/CT in Imaging Cancer Patients Before and

Terminated
  • Malignant Neoplasm
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Aug 10, 2020

Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial in New York (radiation, drug,

Active, not recruiting
  • Acute Lymphoid Leukemia (ALL)
  • +5 more
  • Hyperfractionated total body irradiation
  • +9 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Recurrent Acute Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Burkitt Leukemia Trial in Houston

Recruiting
  • Recurrent Acute Lymphoblastic Leukemia
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2022

Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,

Completed
  • Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
  • Recurrent Childhood B-Lymphoblastic Lymphoma
  • San Diego, California
  • +2 more
Sep 13, 2022

Acute Lymphoblastic Leukemia Trial in La Jolla, San Diego (Alemtuzumab, Clofarabine)

Terminated
  • Acute Lymphoblastic Leukemia
  • Alemtuzumab
  • Clofarabine
  • La Jolla, California
  • +2 more
Jul 29, 2020

High Risk Myeloid Malignancies, Cord Blood Transplant Trial in New York (ECT-001-CB (UM171-Expanded Cord Blood Transplant))

Recruiting
  • High Risk Myeloid Malignancies
  • Cord Blood Transplant
  • ECT-001-CB (UM171-Expanded Cord Blood Transplant)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 12, 2022

Stem Cell Transplantation, Leukemia, Lymphoma Trial in Houston (Thiotepa, Clofarabine, Busulfan)

Completed
  • Stem Cell Transplantation
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 25, 2020

Non-Malignant Hematologic Disorders Trial in New York (Melphalan, Thiotepa, Clofarabine)

Terminated
  • Non-Malignant Hematologic Disorders
  • New York, New York
    Memorial SloanKettering Cancer Center
Mar 1, 2021

Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma Trial in Australia, United States (Prednisone, Vincristine,

Recruiting
  • Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Lymphoma
  • Palo Alto, California
  • +6 more
May 2, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (radiation, drug,

Completed
  • Acute Lymphoblastic Leukemia
  • +3 more
  • total body irradiation
  • +7 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 17, 2021

Leukemia Trial in Houston (Clofarabine, Idarubicin, Cytarabine)

Completed
  • Leukemia
  • Clofarabine
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 17, 2020

Acute Myeloid Leukemia (AML) in Remission, Stem Cell Transplantation Trial in Worldwide (busulfan, cyclophosphamide and

Recruiting
  • Acute Myeloid Leukemia (AML) in Remission
  • Stem Cell Transplantation
  • busulfan, cyclophosphamide and melphalan, BuCyMel
  • clofarabine, fludarabine and busulfan, CloFluBu
  • Brussels, Belgium
  • +16 more
Jul 25, 2022

Myeloid Malignancy, Bone Marrow Failure Syndrome, Transfusion-dependent Red Blood Cell (RBC) Defect Trial in San Francisco

Terminated
  • Myeloid Malignancy
  • +5 more
  • San Francisco, California
    University of California, San Francisco
Feb 25, 2020

Acute Myeloid Leukemia Trial in Aurora, New Orleans, Seattle (procedure, drug, other, radiation)

Completed
  • Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Aurora, Colorado
  • +3 more
Apr 3, 2020

Lymphoma Trial in Portland (biological, drug, genetic, other)

Terminated
  • Lymphoma
  • rituximab
  • +7 more
  • Portland, Oregon
    Knight Cancer Institute at Oregon Health and Science University
Nov 15, 2019

Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia Trial in Columbus, Madison, Milwaukee (Clofarabine, Cyclophosphamide,

Terminated
  • Leukemia, Acute Lymphoblastic
  • Acute Myeloid Leukemia
  • Clofarabine
  • +2 more
  • Columbus, Ohio
  • +3 more
Feb 18, 2020

Myeldysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia, Bone Marrow Diseases Trial run by the NHLBI (Clofarabine,

Completed
  • Myeldysplastic Syndrome (MDS)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

PET Imaging of the Immune System Using Analog Probes

Completed
  • Malignant Melanoma
  • [18F] CFA
  • Los Angeles, California
    University of California, Los Angeles
Oct 8, 2021

Leukemia Trial in Hershey (Clofarabine, Mitoxantrone, Etoposide)

Terminated
  • Leukemia
  • Clofarabine
  • +2 more
  • Hershey, Pennsylvania
    Penn State Hershey Cancer Institute
Jul 22, 2019

Acute Myelogenous Leukemia Trial in Houston (Plerixafor, Clofarabine)

Terminated
  • Acute Myelogenous Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 19, 2019

Leukemia Trial in Houston (Decitabine, Idarubicin, Cytarabine)

Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 28, 2019

Metastatic Solid Tumor Trial (TAC01-CLDN18.2)

Not yet recruiting
  • Metastatic Solid Tumor
  • TAC01-CLDN18.2
  • (no location specified)
May 8, 2023

Myelodysplastic Syndrome, Leukemia Trial in Houston (procedure, drug, other, radiation)

Completed
  • Myelodysplastic Syndrome
  • Leukemia
  • Cord Blood Infusion
  • +11 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 27, 2020

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia

Active, not recruiting
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • +16 more
  • clofarabine
  • +7 more
  • Birmingham, Alabama
  • +268 more
Feb 23, 2021